Ferulic Acid Ester from The Stem Bark of Acacia ataxacantha
Parole chiave:
Acacia ataxacantha, tetradecanyl ferrulate, protein kinaseAbstract
From the chloroform extract of the stem bark of Acacia ataxacantha, a ferrulic acid derivative identified as n-tetradecanyl-3-methoxy-4-hydroxy –trans-cinnamate (tetradecanyl ferulate) compound 2 was isolated for the first time from this plant alongside the triterpene lupenol. The structure of compound 2 was confirmed using NMR and MS and is reported here for the first time. Primary activity of the isolated compound against a panel of disease related protein kinases reveal the compound to be in-active.
Riferimenti bibliografici
Abbas Delazar, Mohammed Shoeb, Yash Kumarasamy, Maureen Byres, Luftun Nahar, Masoud Modarresi and Satyajit D.Sarker (2004). Two bioactive Ferulic acid derivatives from Eremostachys glabra. DARU Vol 12 (2), 49-53
Achenback H., Stocker M., Costenta M. A. (1986). Chemical Investigations of Tropical Medicinal Plants, XXI [1] Long Chain Alkyl Esters of Ferulic and p-Coumaric Acid from Bauhinia manca Zeitschrift fur Naturforschung, 41, 164-168.
Amoussa, AMO; Sanni, A and Lagnika, A (2015). Flavonoids and Flavonol contents of the bark of Acacia ataxacantha. Journ.of Pharmacog. and Phytochem. 4(2), 172-178
Amoussa, AMO; Tchatchedra,M; Lateye, A;A and A Lagnika (2015). Acute toxicity and antifungal effects of Acacia ataxacantha stem bark. Int. Journ. of Pharm& Phytochem.Res. 7(4), 661-668
Amoussa,AMO; L.Lagnika;M.Bourjot;C.V Senecheau and A. Sanni (2016a). Triterpenoids from Acacia ataxacantha DC: antimicrobial and antioxidant activities. BMC comple.Alter.Med. 16, 284.
Amoussa, AMO; L.Lagnika; M.Bourjot; C.V Senecheau and A. Sanni (2016b). New chromone derivative from Acacia ataxacantha and its biological activities. BMC complet.Alter.Med. 16, 506
Ahmadu,A.A; A Agunu; Vassilios Myrianthpoulos and Nikolas Fokialakis (2018). Chemical Constituents of the stem bark of Acacia ataxacantha. Trop. Journ.of Nat. Prod. Res. 2 (8), 380-382
Bach S; Knockaert M; Reinhardt J; Lozach O; Schmitt S; Baratte B; and Koken M (2005). Roscovotine targets, protein kinase and pyridoxal kinase. J. Biol.Chem. 290, 31208-31219
Busse, W (2000).The significance of quality for efficiency and safety control of herbal medicinal products. Drug Inform.Journ. 34(1), 15-23
Buttler,MS (2004).The role of Natural Products for drug discovery. Journ. of Nat. Prod. 67(12), 2141-2153
Calixto,JB(2000).Efficacy, Safety, Quality control and marketing and regulating guidelines for herbal medicines. Braz. Journ.of Biol.Res. 2, 179-189
Capedeville R., Burchdurger E., Zinnermann J., Matter A. (2002). Gilvec (ST1571 Imatinib), A rationally developed target anticancer drug. Nat.Rev Drug Disc 1:493
Ebada,SS; Edrada,RA; Lin W and Proksch,P (2008). Methods for isolation, purification and structural elucidation of bioactive secondary metabolites from marine invertebrates. Nature protocols. 3(12), 1820-1831
Harborne J. B. (1998). Phytochemical methods, a guide to modern technique of plant analysis. London. Chapman and Hall Ltd. Pp 49-188
Hollosyl F, and Keri G. (2004). Plant derived protein tyrosine kinase inhibitors as anti-cancer agents. Curr Med Chem. 4 (2), 173-197
Kareji, AE (2013). Evaluation of herbal drugs used to treat fungal and bacterial diseases in Kenya. Int. Journ.of Herb. Med.Plants. 1(4), 85-87
Katiyar, C; Gupta, A; Kanjilal, K and Kantiyar, S (2012). Drug discovery from plant source: An integrated approach. Int.qauterly Journ. of Research in Ayurveda. 33(1), 10
Lahlou, M (2007). Screening of natural products for drug discovery. Drug discovery. 2(5), 697-705
Macdonald, I; Joseph, OE and Harriet, ME (2010). Documentation of the medicinal plants sold in markets in Abeoukuta, Nigeria. Trop.Journ.of Pharm.Res. 9(2), 110-118
Manning G, Whyte DB, Martinez R, Hunter T, Sudarsanam S. (2002). The protein kinase complement of the human genome. Science. 298, 1912-1934
Newmann,DJ and Cragg GM (2016).Natural Products as sources of New drugs from 1981-2014. Journ. of Nat.Prod.79, 629-661
Newmann,DJ; Cragg,GM and Snader,KM (2000).The influence of Nat.Products upon drug discovery. Nat.Prod.Rep. 17(3), 215-234
Nkengfack,A.E; Vouffo,T.W; Vardamides,J.C; Kouam,J;Fomum,Z.T; Meyer,M and Styerner,O (1997). Phenolic metabolites from Erythrina species. Phytochem. 46(3), 573-578
Rates,SM (2001). Plant as source of drugs. Toxicon. 39(5), 603-613
Seigler D.S (2003). Phytochemistry of Acacia sensu lato. Biochem.Syst.Ecol. 31, 845-873 Patil RL, Balaraman R (2009). Effect of melatonin on doxorubicin testicular damage in rats. Int J PharmTech Res. 1:879-84.
Wagner, H and Bladt, S (2001). Plant drug analysis, a Thin Layer Chromatography. 2nd edition, Springer –Verlag, New York. P 384..
